In fact, the higher expression of Tau/MAPT in lower degree gliomas suggest that it could be an accumulation of this protein in the so-called Proneural tumors, which have a better prognosis and tend to suffer a process of mesenchymalization after tumor recurrence (Bhat et al., 2013). This evidence concerns the gene MAPT and glioma.